Global Donepezil Competitive Landscape Professional Research Report 2025
Research Summary
Donepezil is a medication commonly prescribed to treat symptoms associated with Alzheimer＇s disease and other forms of dementia. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of certain neurotransmitters in the brain, aiding cognitive function and memory. Donepezil is used to improve cognitive abilities, such as memory, thinking, and reasoning, in individuals with mild to moderate Alzheimer＇s disease. It may also help manage behavioral symptoms associated with dementia. While donepezil can provide some symptomatic relief, it does not cure or slow the progression of the underlying disease. It is important for individuals taking donepezil to be monitored by a healthcare professional due to potential side effects and interactions with other medications.
According to DIResearch's in-depth investigation and research, the global Donepezil market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Donepezil include Eisai, Pfizer, Teva, Sandoz, Apotex, Dr Reddy＇s Laboratories, Hansoh Pharma, Sun Pharmaceutical, Cipla, ARK PHA.LTD, Jishengtang Pharma, Luoxin etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Donepezil. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Donepezil market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Donepezil market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Donepezil industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Donepezil Include:
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy＇s Laboratories
Hansoh Pharma
Sun Pharmaceutical
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Donepezil Product Segment Include:
5mg Tables
10mg Tables
23mg Tables
Donepezil Product Application Include:
Mild to Moderate Alzheimer＇s Disease
Moderate to Severe Alzheimer＇s Disease
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Donepezil Industry PESTEL Analysis
Chapter 3: Global Donepezil Industry Porter’s Five Forces Analysis
Chapter 4: Global Donepezil Major Regional Market Size and Forecast Analysis
Chapter 5: Global Donepezil Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Donepezil Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Donepezil Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Donepezil Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Donepezil Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Donepezil Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Donepezil Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Donepezil Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Donepezil Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Donepezil Product by Type
- 1.2.1 5mg Tables
- 1.2.2 10mg Tables
- 1.2.3 23mg Tables
- 1.3 Donepezil Product by Application
- 1.3.1 Mild to Moderate Alzheimer＇s Disease
- 1.3.2 Moderate to Severe Alzheimer＇s Disease
- 1.4 Global Donepezil Market Size Analysis (2020-2032)
- 1.5 Donepezil Market Development Status and Trends
- 1.5.1 Donepezil Industry Development Status Analysis
- 1.5.2 Donepezil Industry Development Trends Analysis
- 2 Donepezil Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Donepezil Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Donepezil Market Analysis by Regions
- 4.1 Donepezil Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Donepezil Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Donepezil Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Donepezil Revenue Forecast by Region (2026-2032)
- 5 Global Donepezil Market Size by Type and Application
- 5.1 Global Donepezil Market Size by Type (2020-2032)
- 5.2 Global Donepezil Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Donepezil Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Donepezil Market Size by Type
- 6.4 North America Donepezil Market Size by Application
- 6.5 North America Donepezil Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Donepezil Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Donepezil Market Size by Type
- 7.4 Europe Donepezil Market Size by Application
- 7.5 Europe Donepezil Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Donepezil Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Donepezil Market Size by Type
- 8.4 China Donepezil Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Donepezil Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Donepezil Market Size by Type
- 9.4 APAC (excl. China) Donepezil Market Size by Application
- 9.5 APAC (excl. China) Donepezil Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Donepezil Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Donepezil Market Size by Type
- 10.4 Latin America Donepezil Market Size by Application
- 10.5 Latin America Donepezil Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Donepezil Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Donepezil Market Size by Type
- 11.4 Middle East & Africa Donepezil Market Size by Application
- 11.5 Middle East & Africa Donepezil Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Donepezil Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Donepezil Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Donepezil Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Eisai
- 13.1.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Eisai Donepezil Product Portfolio
- 13.1.3 Eisai Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Pfizer
- 13.2.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Pfizer Donepezil Product Portfolio
- 13.2.3 Pfizer Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Teva
- 13.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Teva Donepezil Product Portfolio
- 13.3.3 Teva Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Sandoz
- 13.4.1 Sandoz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sandoz Donepezil Product Portfolio
- 13.4.3 Sandoz Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Apotex
- 13.5.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Apotex Donepezil Product Portfolio
- 13.5.3 Apotex Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Dr Reddy＇s Laboratories
- 13.6.1 Dr Reddy＇s Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Dr Reddy＇s Laboratories Donepezil Product Portfolio
- 13.6.3 Dr Reddy＇s Laboratories Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Hansoh Pharma
- 13.7.1 Hansoh Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Hansoh Pharma Donepezil Product Portfolio
- 13.7.3 Hansoh Pharma Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Sun Pharmaceutical
- 13.8.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Sun Pharmaceutical Donepezil Product Portfolio
- 13.8.3 Sun Pharmaceutical Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Cipla
- 13.9.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Cipla Donepezil Product Portfolio
- 13.9.3 Cipla Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 ARK PHA.LTD
- 13.10.1 ARK PHA.LTD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 ARK PHA.LTD Donepezil Product Portfolio
- 13.10.3 ARK PHA.LTD Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Jishengtang Pharma
- 13.11.1 Jishengtang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Jishengtang Pharma Donepezil Product Portfolio
- 13.11.3 Jishengtang Pharma Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Luoxin
- 13.12.1 Luoxin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Luoxin Donepezil Product Portfolio
- 13.12.3 Luoxin Donepezil Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Donepezil Industry Chain Analysis
- 14.2 Donepezil Industry Raw Material and Suppliers Analysis
- 14.2.1 Donepezil Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Donepezil Typical Downstream Customers
- 14.4 Donepezil Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook